Blood Plasma Market
  • Published Date: Aug-2021
  • |
  • 180 Pages
  • |
  • Report ID: HE0898

Blood Plasma Market

The Blood Plasma market is expected to grow from USD 31.67 billion in 2019 to USD 62.82 billion by 2026 at a CAGR of 10% from 2020 to 2026.

  • Report Description
  • Table of Content
  • Segmentation
  • Companies
  • News

Plasma is the fluid part of the blood. Plasma is the flexible part and makes around 55% of the blood. Plasma is the composite blend of in excess of 700 proteins and different substances which are fundamental for the proficient working of the human body. Plasma helps in controlling body temperature and pulse. It fills in as a medium for trade of proteins, supplements and hormones to the diverse parts of the body. Clotting factor, albumin and immunoglobulin are some of the major proteins found in plasma.

The global Blood Plasma market is segregated on the basis of Product as Immunoglobulin, Albumin, Protease Inhibitors, Coagulation Factor Concentrates, and Others. Based on Application the global Blood Plasma market is segmented in Hospitals and Clinics, Research Laboratories, and Academic Institutions.

The global Blood Plasma market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Blood Plasma market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.

Competitive Rivalry

Baxter International, CSL, Grifols, Octapharma, ADMA Biologics, Cerus Corp, Sanquin, Shanghai Raas, TCS Biosciences, and others are among the major players in the global Blood Plasma market. The companies studied in terms of product strategy and various n several growth and expansion strategies to gain a competitive edge in the market. The major players not only follow value chain integration with business operations in multiple stages of the value chain.

The global Blood Plasma market has been segmented as below:

Blood Plasma Market, By Product

  • Immunoglobulin
  • Albumin
  • Protease Inhibitors
  • Coagulation Factor Concentrates
  • Others

Blood Plasma Market, By Application

  • Hospitals and Clinics
  • Research Laboratories
  • Academic Institutions

Blood Plasma Market, By Region

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Blood Plasma Market, By Company

  • Baxter International
  • CSL
  • Grifols
  • Octapharma
  • ADMA Biologics
  • Cerus Corp
  • Sanquin
  • Shanghai Raas
  • TCS Biosciences

The report covers the below scope:

  • Global Blood Plasma market sizes from 2015 to 2024, along with CAGR for 2018-2024
  • Market size comparison for 2017 vs 2024, with actual data for 2017, estimates for 2018 and forecast from 2019 to 2024
  • Global Blood Plasma market trends, covering comprehensive range of consumer trends & manufacturer trends
  • Value chain analysis covering participants from raw material suppliers to the downstream buyer in the global Blood Plasma market
  • Major market opportunities and challenges in forecast timeframe to be focused
  • Competitive landscape with analysis on competition pattern, portfolio comparisons, development trends and strategic management
  • Comprehensive company profiles of the key industry players

The years considered for the study are as follows:

  • Base year - 2018
  • Estimated year - 2019
  • Projected year - 2020
  • Forecast period - 2021 to 2025

Report Scope:

The global Blood Plasma market report scope includes detailed study covering underlying factors influencing the industry trends. The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Blood Plasma market share. Major industry players with significant revenue share include Baxter International, CSL, Grifols, Octapharma, ADMA Biologics, Cerus Corp, Sanquin, Shanghai Raas, TCS Biosciences, and others.

Why to Buy this Report:

  • Gain detailed insights on the Blood Plasma industry trends
  • Find complete analysis on the market status
  • Identify the Blood Plasma market opportunities and growth segments
  • Analyse competitive dynamics by evaluating business segments & product portfolios
  • Facilitate strategy planning and industry dynamics to enhance decision making

Target Audience:

The report targeted towards the existing players in the industry is as follows:

  • Market Manufacturers/Service Providers
  • Market Wholesale/Traders
  • Investment and Financial Institutions

Free and Paid Customization based on the requirement

Report Content

 

  1. Introduction

            1.1 Key Insights

            1.2 Report Overview

            1.3 Markets Covered

            1.4 Stakeholders

  1. Research Methodology

            2.1 Research Scope

            2.2 Market Research Process

            2.3 Research Data Analysis

                        2.4.1 Secondary Research

                        2.4.2 Primary Research

                        2.4.3 Models for Estimation

            2.5 Market Size Estimation

                        2.5.1 Bottom-Up Approach - Segmental Market Analysis

                        2.5.2 Top-Down Approach - Parent Market Analysis

  1. Executive Summary
  2. Market Overview

            4.1 Introduction

                        4.2.1 Drivers

                        4.2.2 Restraints

                        4.2.3 Opportunities

                        4.2.4 Challenges

            4.2 Porter''s Five Force Analysis

  1. Blood Plasma Market, By Product

            5.1 Introduction

            5.2 Immunoglobulin

                        5.2.1 Market Overview

                        5.2.2 Market Size and Forecast

            5.3 Albumin

                        5.3.1 Market Overview

                        5.3.2 Market Size and Forecast

            5.4 Protease Inhibitors

                        5.4.1 Market Overview

                        5.4.2 Market Size and Forecast

            5.5 Coagulation Factor Concentrates

                        5.5.1 Market Overview

                        5.5.2 Market Size and Forecast

            5.6 Others

                        5.6.1 Market Overview

                        5.6.2 Market Size and Forecast

  1. Blood Plasma Market, By Application

            6.1 Introduction

            6.2 Hospitals and Clinics

                        6.2.1 Market Overview

                        6.2.2 Market Size and Forecast

            6.3 Research Laboratories

                        6.3.1 Market Overview

                        6.3.2 Market Size and Forecast

            6.4 Academic Institutions

                        6.4.1 Market Overview

                        6.4.2 Market Size and Forecast

  1. Blood Plasma Market, By Geography

            7.1 Introduction

            7.2 North America

                        7.2.1 North America Blood Plasma, By Product

                        7.2.2 North America Blood Plasma, By Application

            7.3 Europe

                        7.3.1 Europe Blood Plasma, By Product

                        7.3.2 Europe Blood Plasma, By Application

            7.4 Asia-Pacific

                        7.4.1 Asia-Pacific Blood Plasma, By Product

                        7.4.2 Asia-Pacific Blood Plasma, By Application

            7.5 Rest of the World

                        7.5.1 Rest of the World Blood Plasma, By Product

                        7.5.2 Rest of the World Blood Plasma, By Application

  1. Competitive Insights

            8.1 Key Insights

            8.2 Company Market Share Analysis

            8.3 Strategic Outlook

                        8.3.1 Mergers & Acquisitions

                        8.3.2 New Product Development

                        8.3.3 Portfolio/Production Capacity Expansions

                        8.3.4 Joint Ventures, Collaborations, Partnerships & Agreements

                        8.3.5 Others

  1. Company Profiles

            9.1 Baxter International

                        9.1.1 Company Overview

                        9.1.2 Product/Service Landscape

                        9.1.3 Financial Overview

                        9.1.4 Recent Developments

            9.2 CSL

                        9.2.1 Company Overview

                        9.2.2 Product/Service Landscape

                        9.2.3 Financial Overview

                        9.2.4 Recent Developments

            9.3 Grifols

                        9.3.1 Company Overview

                        9.3.2 Product/Service Landscape

                        9.3.3 Financial Overview

                        9.3.4 Recent Developments

            9.4 Octapharma

                        9.4.1 Company Overview

                        9.4.2 Product/Service Landscape

                        9.4.3 Financial Overview

                        9.4.4 Recent Developments

            9.5 ADMA Biologics

                        9.5.1 Company Overview

                        9.5.2 Product/Service Landscape

                        9.5.3 Financial Overview

                        9.5.4 Recent Developments

            9.6 Cerus Corp

                        9.6.1 Company Overview

                        9.6.2 Product/Service Landscape

                        9.6.3 Financial Overview

                        9.6.4 Recent Developments

            9.7 Sanquin

                        9.7.1 Company Overview

                        9.7.2 Product/Service Landscape

                        9.7.3 Financial Overview

                        9.7.4 Recent Developments

            9.8 Shanghai Raas

                        9.8.1 Company Overview

                        9.8.2 Product/Service Landscape

                        9.8.3 Financial Overview

                        9.8.4 Recent Developments

            9.9 TCS Biosciences

                        9.9.1 Company Overview

                        9.9.2 Product/Service Landscape

                        9.9.3 Financial Overview

                        9.9.4 Recent Developments

The global Blood Plasma market has been segmented as below:

Blood Plasma Market, By Product

  • Immunoglobulin
  • Albumin
  • Protease Inhibitors
  • Coagulation Factor Concentrates
  • Others

Blood Plasma Market, By Application

  • Hospitals and Clinics
  • Research Laboratories
  • Academic Institutions

Blood Plasma Market, By Region

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Blood Plasma Market, By Company

  • Baxter International
  • CSL
  • Grifols
  • Octapharma
  • ADMA Biologics
  • Cerus Corp
  • Sanquin
  • Shanghai Raas
  • TCS Biosciences

License Options

  • Single 1500 USD
  • Multiple 3000 USD